Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Adenocarcinoma"" wg kryterium: Temat


Tytuł:
Spatial transcriptomics reveals heterogeneity of histological subtypes between lepidic and acinar lung adenocarcinoma.
Autorzy:
Xie L; Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Kong H; Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai, China.
Yu J; Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.; Department of Thoracic Surgery, Shanghai Geriatric Medical Center, Shanghai, China.
Sun M; Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Lu S; Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai, China.
Zhang Y; Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Hu J; Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Du F; Department of Anesthesiology, Zhongshan Hospital, Fudan University, Shanghai, China.
Lian Q; Gurdon Institute, University of Cambridge, Cambridge, UK.
Xin H; Global Institute of Future Technology, Shanghai Jiao Tong University, Shanghai, China.
Zhou J; Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.; Shanghai Engineer and Technology Research Center of Internet of Things for Respiratory Medicine, Shanghai, China.; Shanghai Key Laboratory of Lung Inflammation and Injury, Shanghai, China.; Shanghai Respiratory Research Institution, Shanghai, China.
Wang X; Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.; Shanghai Institute of Clinical Bioinformatics, Shanghai, China.; Shanghai Engineering Research for AI Technology for Cardiopulmonary Diseases, Fudan University Shanghai Medical College, Shanghai, China.
Powell CA; Pulmonary, Critical Care and Sleep Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Hirsch FR; Tisch Cancer Institute, Center for Thoracic Oncology, Mount Sinai Health System, New York, New York, USA.
Bai C; Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.; Shanghai Engineer and Technology Research Center of Internet of Things for Respiratory Medicine, Shanghai, China.; Shanghai Key Laboratory of Lung Inflammation and Injury, Shanghai, China.; Shanghai Respiratory Research Institution, Shanghai, China.
Song Y; Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.; Shanghai Engineer and Technology Research Center of Internet of Things for Respiratory Medicine, Shanghai, China.; Shanghai Key Laboratory of Lung Inflammation and Injury, Shanghai, China.; Shanghai Respiratory Research Institution, Shanghai, China.
Yin J; Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Yang D; Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.; Shanghai Engineer and Technology Research Center of Internet of Things for Respiratory Medicine, Shanghai, China.; Shanghai Key Laboratory of Lung Inflammation and Injury, Shanghai, China.; Shanghai Respiratory Research Institution, Shanghai, China.; Department of Pulmonary and Critical Care Medicine, Zhongshan Hospital (Xiamen), Fudan University, Xiamen, China.
Pokaż więcej
Źródło:
Clinical and translational medicine [Clin Transl Med] 2024 Feb; Vol. 14 (2), pp. e1573.
Typ publikacji:
Journal Article
MeSH Terms:
Lung Neoplasms*/metabolism
Adenocarcinoma of Lung*/genetics
Adenocarcinoma of Lung*/pathology
Humans ; B7-H1 Antigen/genetics ; Endothelial Cells/metabolism ; Gene Expression Profiling
Czasopismo naukowe
Tytuł:
Combining TIGIT blockade with IL-15 stimulation is a promising immunotherapy strategy for lung adenocarcinoma.
Autorzy:
Luo B; Molecular Diagnosis and Gene Test Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
Sun Y; Molecular Diagnosis and Gene Test Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.; Department of Pathology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
Zhan Q; Molecular Diagnosis and Gene Test Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.; Department of Pathology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
Luo Y; Molecular Diagnosis and Gene Test Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.; Department of Pathology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
Chen Y; Department of Pathology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.; Department of Pathology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, China.
Fu T; Molecular Diagnosis and Gene Test Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.; Department of Pathology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
Yang T; Molecular Diagnosis and Gene Test Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.; Department of Pathology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
Ren L; Molecular Diagnosis and Gene Test Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.; Department of Pathology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
Xie Z; Molecular Diagnosis and Gene Test Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.; Department of Pathology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
Situ X; Molecular Diagnosis and Gene Test Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.; Department of Pathology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
Liu B; Molecular Diagnosis and Gene Test Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
Tang K; Division of Pulmonary and Critical Care Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
Ke Z; Molecular Diagnosis and Gene Test Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.; Department of Pathology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
Pokaż więcej
Źródło:
Clinical and translational medicine [Clin Transl Med] 2024 Jan; Vol. 14 (1), pp. e1553.
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma of Lung*/therapy
Adenocarcinoma of Lung*/metabolism
Lung Neoplasms*/therapy
Lung Neoplasms*/metabolism
Animals ; Humans ; Mice ; CD8-Positive T-Lymphocytes ; Disease Models, Animal ; Immunotherapy ; Interleukin-15/pharmacology ; Receptors, Immunologic/genetics ; Receptors, Immunologic/metabolism ; Tumor Microenvironment
Czasopismo naukowe
Tytuł:
Differential diagnosis of pulmonary nodules and prediction of invasive adenocarcinoma using extracellular vesicle DNA.
Autorzy:
Song C; Department of Cardiothoracic Surgery, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi, Jiangsu, China.; Department of Biomedical Engineering, The Pq Laboratory of BiomeDx/Rx, Binghamton University, Binghamton, New York, USA.
Sun Y; Department of Surgery, Ulm University Hospital, Ulm University, Ulm, Germany.; Department of Surgery, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany.
Chen Y; Department of Biomedical Engineering, The Pq Laboratory of BiomeDx/Rx, Binghamton University, Binghamton, New York, USA.
Shen Y; Department of Computational Biology, Carnegie Mellon University, Pittsburgh, Pennsylvania, USA.
Lei H; Department of Biomedical Engineering, The Pq Laboratory of BiomeDx/Rx, Binghamton University, Binghamton, New York, USA.; Institute of Molecular Medicine, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Mao W; Department of Cardiothoracic Surgery, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi, Jiangsu, China.; Department of Biomedical Engineering, The Pq Laboratory of BiomeDx/Rx, Binghamton University, Binghamton, New York, USA.
Wang J; Yizheng Hospital of Nanjing Drum Tower Hospital Group, Yizheng, Jiangsu, China.; Department of Hematology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, Jiangsu, China.
Wan Y; Department of Biomedical Engineering, The Pq Laboratory of BiomeDx/Rx, Binghamton University, Binghamton, New York, USA.
Pokaż więcej
Źródło:
Clinical and translational medicine [Clin Transl Med] 2024 Feb; Vol. 14 (2), pp. e1582.
Typ publikacji:
Letter
MeSH Terms:
Adenocarcinoma*/diagnosis
Adenocarcinoma*/genetics
Adenocarcinoma*/pathology
Multiple Pulmonary Nodules*/diagnosis
Lung Neoplasms*/diagnosis
Lung Neoplasms*/genetics
Lung Neoplasms*/pathology
Humans ; Diagnosis, Differential
Opinia redakcyjna
Tytuł:
Single-cell profiling reveals tumour cell heterogeneity accompanying a pre-malignant and immunosuppressive microenvironment in gastric adenocarcinoma.
Autorzy:
Ge J; Department of Gastrointestinal Surgery, Xiangya Hospital, Central South University, Changsha, China.
Xiao X; Genomics Institute, Geneplus-Shenzhen, Shenzhen, China.
Zhou H; Department of Pathology, Xiangya Hospital, Central South University, Changsha, China.
Tang M; Institute for Rational and Safe Medication Practices, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China.
Bai J; Geneplus-Beijing Institute, Beijing, China.
Zou X; Geneplus-Beijing Institute, Beijing, China.
Zhang C; Geneplus-Beijing Institute, Beijing, China.
Huang C; The Hunan Provincial Key Laboratory of Precision Diagnosis and Treatment for Gastrointestinal Tumor, Xiangya Hospital, Central South University, Changsha, China.
Feng X; Department of Gastrointestinal Surgery, Xiangya Hospital, Central South University, Changsha, China.
Liu T; Department of Gastrointestinal Surgery, Xiangya Hospital, Central South University, Changsha, China.
Yi X; Geneplus-Beijing Institute, Beijing, China.
Xia X; Geneplus-Beijing Institute, Beijing, China.
Liu H; Department of Gastrointestinal Surgery, Xiangya Hospital, Central South University, Changsha, China.
Chen Z; Department of Gastrointestinal Surgery, Xiangya Hospital, Central South University, Changsha, China.; The Hunan Provincial Key Laboratory of Precision Diagnosis and Treatment for Gastrointestinal Tumor, Xiangya Hospital, Central South University, Changsha, China.; International Joint Research Center of Minimally Invasive Endoscopic Technology Equipment & Standardization, Xiangya Hospital, Central South University, Changsha, China.
Pokaż więcej
Źródło:
Clinical and translational medicine [Clin Transl Med] 2023 Dec; Vol. 13 (12), pp. e1490.
Typ publikacji:
Letter
MeSH Terms:
Adenocarcinoma*/genetics
Adenocarcinoma*/pathology
Stomach Neoplasms*/genetics
Stomach Neoplasms*/pathology
Humans ; Tumor Microenvironment/genetics
Opinia redakcyjna
Tytuł:
Macrophage migration inhibitory factor may contribute to the occurrence of multiple primary lung adenocarcinomas.
Autorzy:
Liu W; Department of Thoracic Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
Yang HS; Department of Thoracic Surgery, China-Japan Friendship Hospital, Beijing, China.
Zhi FH; Department of Thoracic Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
Feng YF; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China.; Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China.
Luo HH; Department of Thoracic Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
Zhu Y; Department of Radiology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
Lei YY; Department of Thoracic Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
Pokaż więcej
Źródło:
Clinical and translational medicine [Clin Transl Med] 2023 Oct; Vol. 13 (10), pp. e1368.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Macrophage Migration-Inhibitory Factors*/genetics
Adenocarcinoma of Lung*/genetics
Adenocarcinoma of Lung*/pathology
Lung Neoplasms*/metabolism
Neoplasms, Multiple Primary*
Humans ; Lung/metabolism ; Tumor Microenvironment/genetics
Czasopismo naukowe
Tytuł:
Identification and validation of GABA-driven subtypes and prognosis signature of lung adenocarcinoma.
Autorzy:
Li L; Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.; National Engineering Laboratory for Internet Medical Systems and Applications, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.; Medical school, Huanghe Science and Technology University, Zhengzhou, Henan, China.
Sun S; National Engineering Laboratory for Internet Medical Systems and Applications, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.; Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Peng M; Department of Clinical Laboratory, Henan No. 3 Provincial People's Hospital, Zhengzhou, Henan, China.
Wu K; Department of Thoracic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Duan X; National Engineering Laboratory for Internet Medical Systems and Applications, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Xue R; National Engineering Laboratory for Internet Medical Systems and Applications, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Yang M; National Engineering Laboratory for Internet Medical Systems and Applications, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Zhang X; National Engineering Laboratory for Internet Medical Systems and Applications, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Zhao J; National Engineering Laboratory for Internet Medical Systems and Applications, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.; Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Pokaż więcej
Źródło:
Clinical and translational medicine [Clin Transl Med] 2023 Oct; Vol. 13 (10), pp. e1450.
Typ publikacji:
Letter; Research Support, Non-U.S. Gov't
MeSH Terms:
Adenocarcinoma of Lung*/diagnosis
Lung Neoplasms*/diagnosis
Lung Neoplasms*/genetics
Lung Neoplasms*/pathology
Humans ; Prognosis ; gamma-Aminobutyric Acid
Raport
Tytuł:
The gut microbiome affects response of treatments in HER2-negative advanced gastric cancer.
Autorzy:
Han Z; Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing, China.; Department of Colorectal Surgery, China-Japan Friendship Hospital, Beijing, China.
Cheng S; Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing, China.; Department of Tumor Chemotherapy and Radiation Sickness, Peking University Third Hospital, Beijing, China.
Dai D; Xbiome, Shenzhen, China.
Kou Y; Xbiome, Shenzhen, China.
Zhang X; Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing, China.
Li F; Xbiome, Shenzhen, China.
Yin X; Xbiome, Shenzhen, China.
Ji J; Xbiome, Shenzhen, China.
Zhang Z; Xbiome, Shenzhen, China.
Wang X; Xbiome, Shenzhen, China.
Zhu N; Xbiome, Shenzhen, China.
Zhang Q; Xbiome, Shenzhen, China.
Tan Y; Xbiome, Shenzhen, China.
Guo X; Institute for Immunology, School of Medicine, Tsinghua University, Beijing, China.
Shen L; Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing, China.
Peng Z; Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing, China.
Pokaż więcej
Źródło:
Clinical and translational medicine [Clin Transl Med] 2023 Jul; Vol. 13 (7), pp. e1312.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Gastrointestinal Microbiome*/genetics
Stomach Neoplasms*/drug therapy
Stomach Neoplasms*/genetics
Adenocarcinoma*
Humans ; B7-H1 Antigen/genetics ; Immune Checkpoint Inhibitors ; Reproducibility of Results ; Lactobacillus
Czasopismo naukowe
Tytuł:
Implementation of deep learning in liver pathology optimizes diagnosis of benign lesions and adenocarcinoma metastasis.
Autorzy:
Kriegsmann M; Institute of Pathology, Heidelberg University, Heidelberg, Germany.; Pathology Wiesbaden, Wiesbaden, Germany.
Kriegsmann K; Department of Hematology, Oncology and Rheumatology, Heidelberg University, Heidelberg, Germany.; Laborarztpraxis Rhein-Main MVZ GbR, Frankfurt am Main, Frankfurt, Germany.
Steinbuss G; Department of Hematology, Oncology and Rheumatology, Heidelberg University, Heidelberg, Germany.
Zgorzelski C; Institute of Pathology, Heidelberg University, Heidelberg, Germany.
Albrecht T; Institute of Pathology, Heidelberg University, Heidelberg, Germany.
Heinrich S; Department of Surgery, JGU-Mainz, University Medical Center Mainz, Mainz, Germany.
Farkas S; Department of Surgery, St. Josefs- Hospital, Wiesbaden, Germany.
Roth W; Institute of Pathology, JGU-Mainz, University Medical Center Mainz, Mainz, Germany.
Dang H; Department of Surgery, Department of Surgical Research, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Hausen A; Institute of Pathology, JGU-Mainz, University Medical Center Mainz, Mainz, Germany.
Gaida MM; Institute of Pathology, JGU-Mainz, University Medical Center Mainz, Mainz, Germany.; TRON, JGU-Mainz, Translational Oncology at the University Medical Center, Mainz, Germany.; Research Center for Immunotherapy, JGU-Mainz, University Medical Center Mainz, Mainz, Germany.
Pokaż więcej
Źródło:
Clinical and translational medicine [Clin Transl Med] 2023 Jul; Vol. 13 (7), pp. e1299.
Typ publikacji:
Journal Article
MeSH Terms:
Deep Learning*
Adenocarcinoma*/diagnosis
Pancreatic Neoplasms*
Liver Neoplasms*/diagnosis
Humans
Czasopismo naukowe
Tytuł:
Colorectal mucinous adenocarcinoma indicates a meaningful subtype: A whole genome sequencing study.
Autorzy:
Xu Y; The First Affiliated Hospital, Cancer Research Institute, Hengyang Medical School, University of South China, Hengyang, P. R. China.; The First Affiliated Hospital, Institute of Clinical Medicine, Hengyang Medical School, University of South China, Hengyang, P. R. China.
Chen X; The First Affiliated Hospital, Cancer Research Institute, Hengyang Medical School, University of South China, Hengyang, P. R. China.; The First Affiliated Hospital, Institute of Clinical Medicine, Hengyang Medical School, University of South China, Hengyang, P. R. China.
Chen Y; Institute of Molecular Precision Medicine and Hunan Key Laboratory of Molecular Precision Medicine, Xiangya Hospital, Central South University, Changsha, P. R. China.
Wu X; The First Affiliated Hospital, Cancer Research Institute, Hengyang Medical School, University of South China, Hengyang, P. R. China.; The First Affiliated Hospital, Department of Gastrointestinal Surgery, Hengyang Medical School, University of South China, Hengyang, P. R. China.
Fang Q; The First Affiliated Hospital, Cancer Research Institute, Hengyang Medical School, University of South China, Hengyang, P. R. China.; The First Affiliated Hospital, Department of Gastrointestinal Surgery, Hengyang Medical School, University of South China, Hengyang, P. R. China.
Tan X; The First Affiliated Hospital, Cancer Research Institute, Hengyang Medical School, University of South China, Hengyang, P. R. China.
Li S; The First Affiliated Hospital, Cancer Research Institute, Hengyang Medical School, University of South China, Hengyang, P. R. China.; The First Affiliated Hospital, Department of Gastrointestinal Surgery, Hengyang Medical School, University of South China, Hengyang, P. R. China.
Huang Q; The First Affiliated Hospital, Department of Gastrointestinal Surgery, Hengyang Medical School, University of South China, Hengyang, P. R. China.
Zu X; The First Affiliated Hospital, Cancer Research Institute, Hengyang Medical School, University of South China, Hengyang, P. R. China.; The First Affiliated Hospital, Institute of Clinical Medicine, Hengyang Medical School, University of South China, Hengyang, P. R. China.
Fu K; Institute of Molecular Precision Medicine and Hunan Key Laboratory of Molecular Precision Medicine, Xiangya Hospital, Central South University, Changsha, P. R. China.
Xiao S; The First Affiliated Hospital, Cancer Research Institute, Hengyang Medical School, University of South China, Hengyang, P. R. China.; The First Affiliated Hospital, Institute of Clinical Medicine, Hengyang Medical School, University of South China, Hengyang, P. R. China.; The First Affiliated Hospital, Department of Gastrointestinal Surgery, Hengyang Medical School, University of South China, Hengyang, P. R. China.
Pokaż więcej
Źródło:
Clinical and translational medicine [Clin Transl Med] 2023 Apr; Vol. 13 (4), pp. e1246.
Typ publikacji:
Letter; Research Support, Non-U.S. Gov't
MeSH Terms:
Colorectal Neoplasms*/genetics
Colorectal Neoplasms*/pathology
Adenocarcinoma, Mucinous*/diagnosis
Adenocarcinoma, Mucinous*/genetics
Adenocarcinoma, Mucinous*/pathology
Humans ; Whole Genome Sequencing
Raport
Tytuł:
Microsecretory adenocarcinoma: Cutaneous counterpart of a newly described salivary gland tumor with recurrent MEF2C::SS18 fusion.
Autorzy:
Panse G; Department of Dermatology, Yale School of Medicine, New Haven, Connecticut, USA.; Department of Pathology, Yale School of Medicine, New Haven, Connecticut, USA.
Pokaż więcej
Źródło:
Journal of cutaneous pathology [J Cutan Pathol] 2023 Feb; Vol. 50 (2), pp. 188-190. Date of Electronic Publication: 2022 Nov 22.
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma*/genetics
Adenocarcinoma*/pathology
Salivary Gland Neoplasms*/genetics
Salivary Gland Neoplasms*/pathology
Humans ; Biomarkers, Tumor ; Immunohistochemistry ; MEF2 Transcription Factors
Czasopismo naukowe
Tytuł:
Integrated metabolic and genetic analysis reveals distinct features of human differentiated thyroid cancer.
Autorzy:
Cararo Lopes E; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.; Department of Molecular Biology and Biochemistry, Rutgers University, Piscataway, New Jersey, USA.
Sawant A; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.
Moore D; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.; Department of Biostatistics and Epidemiology, Rutgers School of Public Health, Piscataway, New Jersey, USA.
Ke H; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.
Shi F; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.
Laddha S; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.
Chen Y; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.
Sharma A; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.
Naumann J; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.
Guo JY; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.; Department of Medicine, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, New Jersey, USA.; Department of Chemical Biology, Rutgers Ernest Mario School of Pharmacy, Piscataway, New Jersey, USA.
Gomez M; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.
Ibrahim M; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.
Smith TL; Rutgers Cancer Institute of New Jersey, Newark, New Jersey, USA.; Division of Cancer Biology, Department of Radiation Oncology, Rutgers New Jersey Medical School, Newark, New Jersey, USA.
Riedlinger GM; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.
Lattime EC; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.; Department of Surgery, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, New Jersey, USA.
Trooskin S; Department of Surgery, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, New Jersey, USA.
Ganesan S; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.; Department of Medicine, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, New Jersey, USA.
Su X; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.; Department of Medicine, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, New Jersey, USA.
Pasqualini R; Rutgers Cancer Institute of New Jersey, Newark, New Jersey, USA.; Division of Cancer Biology, Department of Radiation Oncology, Rutgers New Jersey Medical School, Newark, New Jersey, USA.
Arap W; Rutgers Cancer Institute of New Jersey, Newark, New Jersey, USA.; Division of Hematology/Oncology, Department of Medicine, Rutgers New Jersey Medical School, Newark, New Jersey, USA.
De S; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.
Chan CS; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.; Department of Medicine, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, New Jersey, USA.
White E; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.; Department of Molecular Biology and Biochemistry, Rutgers University, Piscataway, New Jersey, USA.; Ludwig Princeton Branch, Ludwig Institute for Cancer Research, Princeton University, Princeton, New Jersey, USA.
Pokaż więcej
Źródło:
Clinical and translational medicine [Clin Transl Med] 2023 Jun; Vol. 13 (6), pp. e1298.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
MeSH Terms:
Thyroid Neoplasms*/diagnosis
Thyroid Neoplasms*/genetics
Adenocarcinoma*
Humans ; Iodine Radioisotopes/therapeutic use ; Prospective Studies ; Quality of Life ; Telomere Shortening ; Telomere ; Neoplasm Recurrence, Local
Czasopismo naukowe
Tytuł:
Microsecretory adenocarcinoma of the external ear canal.
Autorzy:
Dibbern ME; Department of Pathology, University of Virginia Medical Center, Charlottesville, Virginia, USA.
Gru AA; Department of Pathology, University of Virginia Medical Center, Charlottesville, Virginia, USA.
Stelow EB; Department of Pathology, University of Virginia Medical Center, Charlottesville, Virginia, USA.
Pokaż więcej
Źródło:
Journal of cutaneous pathology [J Cutan Pathol] 2023 Feb; Vol. 50 (2), pp. 106-109. Date of Electronic Publication: 2022 Jul 11.
Typ publikacji:
Case Reports
MeSH Terms:
Adenocarcinoma*/pathology
Salivary Gland Neoplasms*/genetics
Female ; Humans ; Aged, 80 and over ; In Situ Hybridization, Fluorescence ; Ear Canal/metabolism ; Ear Canal/pathology ; Immunohistochemistry ; S100 Proteins/genetics ; Biomarkers, Tumor/genetics
Raport
Tytuł:
Microsecretory adenocarcinoma of the skin harboring recurrent SS18 fusions: A cutaneous analog to a newly described salivary gland tumor.
Autorzy:
Bishop JA; Department of Pathology, UT Southwestern Medical Center, Dallas, Texas, USA.
Williams EA; UCSF Dermatopathology & Oral Pathology Service, Department of Pathology and Dermatology, University of California, San Francisco, California, USA.
McLean AC; Department of Pathology, UT Southwestern Medical Center, Dallas, Texas, USA.
Gagan J; Department of Pathology, UT Southwestern Medical Center, Dallas, Texas, USA.
Rooper LM; Department of Pathology, The Johns Hopkins Hospital, Baltimore, Maryland, USA.
Jordan RCK; UCSF Dermatopathology & Oral Pathology Service, Department of Pathology and Dermatology, University of California, San Francisco, California, USA.
LeBoit PE; UCSF Dermatopathology & Oral Pathology Service, Department of Pathology and Dermatology, University of California, San Francisco, California, USA.
Pokaż więcej
Źródło:
Journal of cutaneous pathology [J Cutan Pathol] 2023 Feb; Vol. 50 (2), pp. 134-139. Date of Electronic Publication: 2022 Jul 11.
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma*/genetics
Salivary Gland Neoplasms*/genetics
Salivary Gland Neoplasms*/pathology
Carcinoma*/pathology
Skin Neoplasms*/genetics
Skin Neoplasms*/pathology
Humans ; In Situ Hybridization, Fluorescence ; Biomarkers, Tumor/genetics
Czasopismo naukowe
Tytuł:
LncRNA BC promotes lung adenocarcinoma progression by modulating IMPAD1 alternative splicing.
Autorzy:
Chen QW; Department of Integrative Oncology, Fudan University Shanghai Cancer Center, Shanghai, P. R. China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, P. R. China.
Cai QQ; Shanghai Key Laboratory of Molecular Imaging, Shanghai University of Medicine and Health Sciences, Shanghai, P. R. China.
Yang Y; Key Laboratory of Glycoconjugate Research Ministry of Public Health, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, P. R. China.
Dong S; Department of Integrative Oncology, Fudan University Shanghai Cancer Center, Shanghai, P. R. China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, P. R. China.
Liu YY; Key Laboratory of Glycoconjugate Research Ministry of Public Health, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, P. R. China.
Chen ZY; Key Laboratory of Glycoconjugate Research Ministry of Public Health, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, P. R. China.
Kang CL; Key Laboratory of Glycoconjugate Research Ministry of Public Health, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, P. R. China.
Qi B; Key Laboratory of Glycoconjugate Research Ministry of Public Health, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, P. R. China.
Dong YW; Key Laboratory of Glycoconjugate Research Ministry of Public Health, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, P. R. China.
Wu W; Department of Pathology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, P. R. China.
Zhuang LP; Department of Integrative Oncology, Fudan University Shanghai Cancer Center, Shanghai, P. R. China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, P. R. China.
Shen YH; Department of Integrative Oncology, Fudan University Shanghai Cancer Center, Shanghai, P. R. China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, P. R. China.
Meng ZQ; Department of Integrative Oncology, Fudan University Shanghai Cancer Center, Shanghai, P. R. China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, P. R. China.
Wu XZ; Key Laboratory of Glycoconjugate Research Ministry of Public Health, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, P. R. China.
Pokaż więcej
Źródło:
Clinical and translational medicine [Clin Transl Med] 2023 Jan; Vol. 13 (1), pp. e1129.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Adenocarcinoma*/genetics
Adenocarcinoma*/pathology
Alternative Splicing*/genetics
Lung Neoplasms*/pathology
RNA, Long Noncoding*/metabolism
Humans ; Cell Line, Tumor ; ErbB Receptors/genetics ; ErbB Receptors/metabolism ; Lung/metabolism
Czasopismo naukowe
Tytuł:
Perianal Paget disease associated with non-invasive colorectal adenoma.
Autorzy:
Zuo Z; Department of Pathology, First Hospital of Jiaxing, Jiaxing, China.
Wu W; Department of Pathology, First Hospital of Jiaxing, Jiaxing, China.
Li X; Department of Pathology, First Hospital of Jiaxing, Jiaxing, China.
Zhang L; Department of Pathology, First Hospital of Jiaxing, Jiaxing, China.
Wang J; Department of Pathology, First Hospital of Jiaxing, Jiaxing, China.
Guo Z; Department of Pathology, First Hospital of Jiaxing, Jiaxing, China.
Hu S; Department of Pathology, First Hospital of Jiaxing, Jiaxing, China.
Zhang Q; Graduate School of Nursing, Huzhou University, Huzhou, China.
Pokaż więcej
Źródło:
Journal of cutaneous pathology [J Cutan Pathol] 2023 Jan; Vol. 50 (1), pp. 35-38. Date of Electronic Publication: 2022 Sep 09.
Typ publikacji:
Case Reports
MeSH Terms:
Anus Neoplasms*/diagnosis
Anus Neoplasms*/drug therapy
Anus Neoplasms*/pathology
Skin Neoplasms*/pathology
Adenocarcinoma*
Paget Disease, Extramammary*/diagnosis
Humans ; Skin/pathology
Raport
Tytuł:
Melatonin may suppress lung adenocarcinoma progression via regulation of the circular noncoding RNA hsa_circ_0017109/miR-135b-3p/TOX3 axis.
Autorzy:
Wang Y; Department of Thoracic Surgery, Tangdu Hospital of Air Force Military Medical University, Xi'an, China.
Wang Z; Department of Thoracic Surgery, Tangdu Hospital of Air Force Military Medical University, Xi'an, China.
Shao C; Department of Thoracic Surgery, Tangdu Hospital of Air Force Military Medical University, Xi'an, China.
Lu G; Department of Physiology and Pathophysiology, National Key Discipline of Cell Biology, Fourth Military Medical University, Xi'an, China.; State Key Laboratory of Cancer Biology and National Clinical Research Center for Digestive Diseases, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an, China.
Xie M; Department of Respiratory and Critical Care, Chinese PLA General Hospital, Beijing, China.
Wang J; Department of Thoracic Surgery, Tangdu Hospital of Air Force Military Medical University, Xi'an, China.
Duan H; Department of Thoracic Surgery, Tangdu Hospital of Air Force Military Medical University, Xi'an, China.
Li X; Department of Thoracic Surgery, Xi'an International Medical Center Hospital, Xi'an, China.
Yu W; School of Basic Medicine, Qingdao University, Qingdao, China.
Duan W; Department of Cardiovascular Surgery, Xijing Hospital of Fourth Military Medical University, Xi'an, China.
Yan X; Department of Thoracic Surgery, Tangdu Hospital of Air Force Military Medical University, Xi'an, China.
Pokaż więcej
Źródło:
Journal of pineal research [J Pineal Res] 2022 Sep; Vol. 73 (2), pp. e12813. Date of Electronic Publication: 2022 Jun 12.
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma of Lung*/genetics
Adenocarcinoma of Lung*/metabolism
Adenocarcinoma of Lung*/pathology
Carcinoma, Non-Small-Cell Lung*
Lung Neoplasms*/metabolism
Melatonin*/pharmacology
MicroRNAs*/genetics
MicroRNAs*/metabolism
Cell Line, Tumor ; Cell Proliferation/genetics ; Disease Progression ; Humans
Czasopismo naukowe
Tytuł:
The VRAC blocker DCPIB directly gates the BK channels and increases intracellular Ca in melanoma and pancreatic duct adenocarcinoma cell lines.
Autorzy:
Zuccolini P; Institute of Biophysics, National Research Council, Genoa, Italy.
Ferrera L; Institute of Biophysics, National Research Council, Genoa, Italy.; U.O.C. Genetica Medica, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Istituto Giannina Gaslini, Genoa, Italy.
Remigante A; Institute of Biophysics, National Research Council, Genoa, Italy.
Picco C; Institute of Biophysics, National Research Council, Genoa, Italy.
Barbieri R; Institute of Biophysics, National Research Council, Genoa, Italy.
Bertelli S; Institute of Biophysics, National Research Council, Genoa, Italy.
Moran O; Institute of Biophysics, National Research Council, Genoa, Italy.
Gavazzo P; Institute of Biophysics, National Research Council, Genoa, Italy.
Pusch M; Institute of Biophysics, National Research Council, Genoa, Italy.
Pokaż więcej
Źródło:
British journal of pharmacology [Br J Pharmacol] 2022 Jul; Vol. 179 (13), pp. 3452-3469. Date of Electronic Publication: 2022 Feb 28.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Adenocarcinoma*
Melanoma*/drug therapy
Melanoma*/metabolism
Anions/metabolism ; HEK293 Cells ; Humans ; Large-Conductance Calcium-Activated Potassium Channels ; Pancreatic Ducts/metabolism
Czasopismo naukowe
Tytuł:
Elevation of fatty acid desaturase 2 in esophageal adenocarcinoma increases polyunsaturated lipids and may exacerbate bile acid-induced DNA damage.
Autorzy:
Molendijk J; The University of Queensland Diamantina Institute, Faculty of Medicine, The University of Queensland, Woolloongabba, Australia.; Precision and Systems Biomedicine Laboratory, QIMR Berghofer Medical Research Institute, Herston, Australia.
Kolka CM; Precision and Systems Biomedicine Laboratory, QIMR Berghofer Medical Research Institute, Herston, Australia.
Cairns H; Precision and Systems Biomedicine Laboratory, QIMR Berghofer Medical Research Institute, Herston, Australia.
Brosda S; The University of Queensland Diamantina Institute, Faculty of Medicine, The University of Queensland, Woolloongabba, Australia.
Mohamed A; The University of Queensland Diamantina Institute, Faculty of Medicine, The University of Queensland, Woolloongabba, Australia.; Precision and Systems Biomedicine Laboratory, QIMR Berghofer Medical Research Institute, Herston, Australia.
Shah AK; The University of Queensland Diamantina Institute, Faculty of Medicine, The University of Queensland, Woolloongabba, Australia.; Precision and Systems Biomedicine Laboratory, QIMR Berghofer Medical Research Institute, Herston, Australia.
Brown I; Envoi Pathology, Herston, Australia.
Hodson MP; School of Pharmacy, The University of Queensland, Woolloongabba, Australia.
Hennessy T; The University of Queensland Diamantina Institute, Faculty of Medicine, The University of Queensland, Woolloongabba, Australia.; Agilent Technologies, Mulgrave, Australia.
Liu G; Precision and Systems Biomedicine Laboratory, QIMR Berghofer Medical Research Institute, Herston, Australia.
Stoll T; Precision and Systems Biomedicine Laboratory, QIMR Berghofer Medical Research Institute, Herston, Australia.
Richards RS; Precision and Systems Biomedicine Laboratory, QIMR Berghofer Medical Research Institute, Herston, Australia.
Gartside M; The University of Queensland Diamantina Institute, Faculty of Medicine, The University of Queensland, Woolloongabba, Australia.
Patel K; The University of Queensland Diamantina Institute, Faculty of Medicine, The University of Queensland, Woolloongabba, Australia.
Clemons NJ; Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia.
Phillips WA; Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia.
Barbour A; The University of Queensland Diamantina Institute, Faculty of Medicine, The University of Queensland, Woolloongabba, Australia.
Westerhuis JA; Swammerdam Institute for Life Sciences, University of Amsterdam, Amsterdam, The Netherlands.
Hill MM; The University of Queensland Diamantina Institute, Faculty of Medicine, The University of Queensland, Woolloongabba, Australia.; Precision and Systems Biomedicine Laboratory, QIMR Berghofer Medical Research Institute, Herston, Australia.
Pokaż więcej
Źródło:
Clinical and translational medicine [Clin Transl Med] 2022 May; Vol. 12 (5), pp. e810.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Adenocarcinoma*/genetics
Adenocarcinoma*/metabolism
Adenocarcinoma*/pathology
Barrett Esophagus*/genetics
Barrett Esophagus*/metabolism
Barrett Esophagus*/pathology
Bile Acids and Salts ; DNA Damage/genetics ; Esophageal Neoplasms ; Fatty Acid Desaturases/genetics ; Fatty Acid Desaturases/metabolism ; Fatty Acids ; Humans ; Sphingolipids
SCR Disease Name:
Adenocarcinoma Of Esophagus
Czasopismo naukowe
Tytuł:
Single-cell transcriptomic analysis reveals circadian rhythm disruption associated with poor prognosis and drug-resistance in lung adenocarcinoma.
Autorzy:
He L; Department of Blood Transfusion, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Fan Y; Department of Biochemistry and Molecular Biology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Zhang Y; Department of Blood Transfusion, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Tu T; Department of Blood Transfusion, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Zhang Q; Department of Laboratory Medicine, Hubei Provincial Hospital of Integrated Chinese and Western Medicine, Wuhan, China.
Yuan F; School of Medicine, Jianghan University, Wuhan, China.
Cheng C; Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Pokaż więcej
Źródło:
Journal of pineal research [J Pineal Res] 2022 Aug; Vol. 73 (1), pp. e12803. Date of Electronic Publication: 2022 Apr 27.
Typ publikacji:
Journal Article
MeSH Terms:
Adenocarcinoma of Lung*/genetics
Lung Neoplasms*/genetics
Lung Neoplasms*/pathology
Melatonin*
Circadian Rhythm/physiology ; Humans ; Prognosis ; Transcriptome
Czasopismo naukowe
Tytuł:
Response to: Cutaneous papillary adenocarcinoma in situ.
Autorzy:
Patel K; Department of Pathology, Texas Children's Hospital, Houston, Texas.
Wu H; Department of Pathology, Texas Children's Hospital, Houston, Texas.
Pimpalwar A; Department of Surgery, Texas Children's Hospital, Houston, Texas.
Diwan AH; Department of Pathology, Baylor College of Medicine, Houston, Texas.
Pokaż więcej
Źródło:
Journal of cutaneous pathology [J Cutan Pathol] 2017 Jun; Vol. 44 (6), pp. 598-599. Date of Electronic Publication: 2017 Mar 16.
Typ publikacji:
Letter; Comment
MeSH Terms:
Adenocarcinoma, Papillary*
Skin Neoplasms*
Adenocarcinoma ; Humans
Opinia redakcyjna

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies